Canaan Partners XI 13FHR Quarterly holdings report by institutional manager | SEC 31 Oct 22

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.

COLUMN 1	COLUMN 2	COLUMN 3	COLUMN 4	COLUMN 5			COLUMN 6	COLUMN 7	COLUMN 8
			VALUE	SHRS OR	SH/	PUT/	INVESTMENT	OTHER	VOTING AUTHORITY
NAME OF ISSUER	TITLE OF CLASS	CUSIP	(x$1000)	PRN AMT	PRN	CALL	DISCRETION	MANAGER	SOLE	SHARED	NONE
AEVA TECHNOLOGIES INC	COM	00835Q103	34,567	18,485,197	SH		SOLE		18,485,197	0	0
BIRD GLOBAL INC	COM CL A	09077J107	24	69,270	SH		SOLE		69,270	0	0
DAY ONE BIOPHARHACEUTICALS I	COM	23954D109	139,495	6,964,301	SH		SOLE		6,964,301	0	0
RALLYBIO CORP	COM	75120L100	34,869	2,409,712	SH		SOLE		2,409,712	0	0
TYRA BIOSCIENCES INC	COM	90240B106	38,764	4,409,991	SH		SOLE		4,409,991	0	0
VECTIVBIO HLDG AG	ORD SHS	H9060V101	222	37,051	SH		SOLE		37,051	0	0

Canaan Partners XI 13F-HRQuarterly holdings report by institutional manager